Chronic liver disease patients requiring long-term regular anticoagulant therapy
Conditions
Interventions
Control group:None
Study group:None
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Chinese male or female patients, age >= 18 years; 2. Long-term or regular anticoagulation therapy needs to be started; 3. Patients with chronic liver disease (Child-Pugh grade A/B/C) at the time of initiation of anticoagulation therapy; 4. Normal renal function or mild-moderate injury (eGFR >= 60 mL/min/1.73m^2).
Exclusion criteria
Exclusion criteria: 1.The initiation time of regular anticoagulant therapy is unknown; 2.Discontinuation of anticoagulant therapy within 1 month after initiation due to events such as bleeding/embolism; 3.Use of low-molecular-weight heparin for anticoagulant therapy; 4.Inability to obtain complete medical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thromboembolic events;Bleeding events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Compliance outcomes; | — |
Countries
China
Contacts
Public ContactPengfei Jin
Beijing Hospital
Outcome results
None listed